PROTEIN GOLDING-BASED TDP-43-TARGETING GENE THERAPY FOR ALS

$1,392,575FY2025Defense Health AgencyDOD

Sola Biosciences, Inc

Investigators

View source on USAspending →

PROTEIN GOLDING-BASED TDP-43-TARGETING GENE THERAPY FOR ALS · GrantIndex